FWBI Insider Trading Activity and SEC Form 4 Filings
FWBI insider trading summary
No open-market insider purchases or sales of First Wave BioPharma, Inc. (FWBI) have been reported on SEC Form 4 in the past 12 months.
Latest FWBI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 1, 2024 | Sarah Romano | Chief Financial Officer | Sell | $317 (75 @ $4.23) |
| Apr 1, 2024 | James Sapirstein | Chairman and CEO | Sell | $736 (174 @ $4.23) |
| Mar 15, 2024 | Sarah Romano | Chief Financial Officer | Sell | $6K (1,120 @ $4.96) |
| Mar 15, 2024 | James Sapirstein | Chairman and CEO | Sell | $9K (1,887 @ $4.96) |
| Jan 12, 2024 | Sarah Romano | Chief Financial Officer | Sell | $412 (98 @ $4.20) |
| Jan 12, 2024 | James Sapirstein | Chairman, President and CEO | Sell | $697 (166 @ $4.20) |
| Oct 4, 2023 | Sarah Romano | Chief Financial Officer | Sell | $486 (1,676 @ $0.29) |
| Oct 4, 2023 | James Sapirstein | President and CEO | Sell | $802 (2,764 @ $0.29) |
| Sep 15, 2023 | Charles J Casamento | Director | Sell | $4 (10 @ $0.43) |
| Aug 31, 2023 | Charles J Casamento | Director | Sell | $2K (6,053 @ $0.30) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.